238 related articles for article (PubMed ID: 34486178)
41. Holding open the door reveals a new view of polycystin channel function.
Caplan MJ
EMBO Rep; 2019 Nov; 20(11):e49156. PubMed ID: 31556469
[TBL] [Abstract][Full Text] [Related]
42. Regulation of polycystin-1 ciliary trafficking by motifs at its C-terminus and polycystin-2 but not by cleavage at the GPS site.
Su X; Wu M; Yao G; El-Jouni W; Luo C; Tabari A; Zhou J
J Cell Sci; 2015 Nov; 128(22):4063-73. PubMed ID: 26430213
[TBL] [Abstract][Full Text] [Related]
43. Dnajb11-Kidney Disease Develops from Reduced Polycystin-1 Dosage but not Unfolded Protein Response in Mice.
Ghosh Roy S; Li Z; Guo Z; Long KT; Rehrl S; Tian X; Dong K; Besse W
J Am Soc Nephrol; 2023 Sep; 34(9):1521-1534. PubMed ID: 37332102
[TBL] [Abstract][Full Text] [Related]
44. A role for polycystin-1 and polycystin-2 in neural progenitor cell differentiation.
Winokurow N; Schumacher S
Cell Mol Life Sci; 2019 Jul; 76(14):2851-2869. PubMed ID: 30895336
[TBL] [Abstract][Full Text] [Related]
45. Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease.
Bastos AP; Onuchic LF
Braz J Med Biol Res; 2011 Jul; 44(7):606-17. PubMed ID: 21625823
[TBL] [Abstract][Full Text] [Related]
46. A mutation affecting polycystin-1 mediated heterotrimeric G-protein signaling causes PKD.
Parnell SC; Magenheimer BS; Maser RL; Pavlov TS; Havens MA; Hastings ML; Jackson SF; Ward CJ; Peterson KR; Staruschenko A; Calvet JP
Hum Mol Genet; 2018 Oct; 27(19):3313-3324. PubMed ID: 29931260
[TBL] [Abstract][Full Text] [Related]
47. The Sorting Nexin 3 Retromer Pathway Regulates the Cell Surface Localization and Activity of a Wnt-Activated Polycystin Channel Complex.
Feng S; Streets AJ; Nesin V; Tran U; Nie H; Onopiuk M; Wessely O; Tsiokas L; Ong ACM
J Am Soc Nephrol; 2017 Oct; 28(10):2973-2984. PubMed ID: 28620080
[TBL] [Abstract][Full Text] [Related]
48. Retromer associates with the cytoplasmic amino-terminus of polycystin-2.
Tilley FC; Gallon M; Luo C; Danson CM; Zhou J; Cullen PJ
J Cell Sci; 2018 Jun; 131(11):. PubMed ID: 29724910
[TBL] [Abstract][Full Text] [Related]
49. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
Wu G
Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
[TBL] [Abstract][Full Text] [Related]
50. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
Harris PC
Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
[TBL] [Abstract][Full Text] [Related]
51. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
[TBL] [Abstract][Full Text] [Related]
52. Role of apoptosis in the development of autosomal dominant polycystic kidney disease (ADPKD).
Peintner L; Borner C
Cell Tissue Res; 2017 Jul; 369(1):27-39. PubMed ID: 28560694
[TBL] [Abstract][Full Text] [Related]
53. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
[TBL] [Abstract][Full Text] [Related]
54. Transport function of the naturally occurring pathogenic polycystin-2 mutant, R742X.
Chen XZ; Segal Y; Basora N; Guo L; Peng JB; Babakhanlou H; Vassilev PM; Brown EM; Hediger MA; Zhou J
Biochem Biophys Res Commun; 2001 Apr; 282(5):1251-6. PubMed ID: 11302751
[TBL] [Abstract][Full Text] [Related]
55. Polycystin-1 Interacting Protein-1 (CU062) Interacts with the Ectodomain of Polycystin-1 (PC1).
Lea WA; Winklhofer T; Zelenchuk L; Sharma M; Rossol-Allison J; Fields TA; Reif G; Calvet JP; Bakeberg JL; Wallace DP; Ward CJ
Cells; 2023 Aug; 12(17):. PubMed ID: 37681898
[TBL] [Abstract][Full Text] [Related]
56. Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy.
Paavola J; Schliffke S; Rossetti S; Kuo IY; Yuan S; Sun Z; Harris PC; Torres VE; Ehrlich BE
J Mol Cell Cardiol; 2013 May; 58():199-208. PubMed ID: 23376035
[TBL] [Abstract][Full Text] [Related]
57. Regulation of Polycystin-1 Function by Calmodulin Binding.
Doerr N; Wang Y; Kipp KR; Liu G; Benza JJ; Pletnev V; Pavlov TS; Staruschenko A; Mohieldin AM; Takahashi M; Nauli SM; Weimbs T
PLoS One; 2016; 11(8):e0161525. PubMed ID: 27560828
[TBL] [Abstract][Full Text] [Related]
58. Expression of the polycystin-1 C-terminal cytoplasmic tail increases Cl channel activity in Xenopus oocytes.
Chernova MN; Vandorpe DH; Clark JS; Alper SL
Kidney Int; 2005 Aug; 68(2):632-41. PubMed ID: 16014040
[TBL] [Abstract][Full Text] [Related]
59. Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin.
Kim I; Ding T; Fu Y; Li C; Cui L; Li A; Lian P; Liang D; Wang DW; Guo C; Ma J; Zhao P; Coffey RJ; Zhan Q; Wu G
J Am Soc Nephrol; 2009 Dec; 20(12):2556-69. PubMed ID: 19939939
[TBL] [Abstract][Full Text] [Related]
60. Role of calcium in polycystic kidney disease: From signaling to pathology.
Mangolini A; de Stephanis L; Aguiari G
World J Nephrol; 2016 Jan; 5(1):76-83. PubMed ID: 26788466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
